This summer, the U.S. Department of Agriculture (USDA) is finalizing new national rules for labeling and marketing lab-grown ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.

The proposal of the Department of Trade and Industry (DTI) to authorize sari-sari stores to sell over-the-counter (OTC) drugs has raised eyebrows of groups of ...